PERCEPTIVE ADVISORS LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$6.5B
Holdings
145
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (145 positions)
| Stock | Value |
|---|---|
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $484.7M |
MRTXEURMIRATI THERAPEUTICS INC | $481.7M |
LIANYLIANBIO | $346.9M |
AM6AMICUS THERAPEUTICS INC | $306.8M |
SWTXSPRINGWORKS THERAPEUTICS INC | $300.6M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $193.3M |
HZNPHORIZON THERAPEUTICS PUB L | $187.3M |
—COLLEGIUM PHARMACEUTICAL INC | $169.3M |
MGTXMEIRAGTX HLDGS PLC | $165.0M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $164.9M |
CRNXCRINETICS PHARMACEUTICALS IN | $146.7M |
—PROMETHEUS BIOSCIENCES INC | $125.5M |
VAC2USDVBI VACCINES INC CDA | $122.5M |
BBIOBRIDGEBIO PHARMA INC | $118.9M |
OPHTEURIVERIC BIO INC | $108.3M |
RAPTEURRAPT THERAPEUTICS INC | $107.5M |
BMRNBIOMARIN PHARMACEUTICAL INC | $104.3M |
NVRO 2.75 04/01/25NEVRO CORP | $101.5M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $101.0M |
CHRSCOHERUS BIOSCIENCES INC | $86.3M |
OMGBPOUTSET MED INC | $85.9M |
XENEXENON PHARMACEUTICALS INC | $75.3M |
—LANDOS BIOPHARMA INC | $71.4M |
CCCCC4 THERAPEUTICS INC | $71.1M |
APLSAPELLIS PHARMACEUTICALS INC | $68.6M |
BLUBELLUS HEALTH INC NEW | $61.5M |
—ZYMEWORKS INC | $60.3M |
RLAYRELAY THERAPEUTICS INC | $59.7M |
INBXUSDINHIBRX INC | $58.7M |
TVTXTRAVERE THERAPEUTICS INC | $57.3M |
BDQMALBIREO PHARMA INC | $55.0M |
CCXIEURCHEMOCENTRYX INC | $51.5M |
—COHERUS BIOSCIENCES INC | $51.5M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $47.2M |
ARNAEURARENA PHARMACEUTICALS INC | $46.5M |
—ATHIRA PHARMA INC | $44.6M |
KODKODIAK SCIENCES INC | $44.1M |
—ICOSAVAX INC | $43.6M |
RCKTROCKET PHARMACEUTICALS INC | $42.8M |
—QUOTIENT LTD | $42.0M |
NBIXNEUROCRINE BIOSCIENCES INC | $41.1M |
MORFMORPHIC HLDG INC | $39.6M |
ALDXALDEYRA THERAPEUTICS INC | $39.6M |
—SINGULAR GENOMICS SYSTEMS IN | $38.5M |
—ISOPLEXIS CORP | $37.6M |
ACADACADIA PHARMACEUTICALS INC | $37.0M |
ZNTLZENTALIS PHARMACEUTICALS INC | $36.2M |
IMTXIMMATICS N.V | $33.6M |
PRCTPROCEPT BIOROBOTICS CORP | $33.2M |
VRCAVERRICA PHARMACEUTICALS INC | $33.1M |
KRON1USDKRONOS BIO INC | $32.9M |
—RAIN THERAPEUTICS INC | $32.0M |
TARSTARSUS PHARMACEUTICALS INC | $29.2M |
VRDNVIRIDIAN THERAPEUTICS INC | $28.1M |
LPTXEURLEAP THERAPEUTICS INC | $27.5M |
ESTAESTABLISHMENT LABS HLDGS INC | $27.4M |
COGTCOGENT BIOSCIENCES INC | $27.4M |
—CAREMAX INC | $27.3M |
MGNXMACROGENICS INC | $26.7M |
VERUEURVERU INC | $26.2M |
NUVBNUVATION BIO INC | $24.8M |
LUNGPULMONX CORP | $24.4M |
NVTA1EURINVITAE CORP | $24.2M |
SLDBSOLID BIOSCIENCES INC | $23.5M |
PYXSPYXIS ONCOLOGY INC | $21.3M |
HLTHQCUE HEALTH INC | $21.2M |
UTHUNITED THERAPEUTICS CORP DEL | $20.3M |
VRNAVERONA PHARMA PLC | $19.3M |
—SCIENCE 37 HOLDINGS INC | $18.7M |
ATNXEURATHENEX INC | $18.4M |
TMCITREACE MED CONCEPTS INC | $18.3M |
HCATHEALTH CATALYST INC | $18.0M |
—DICE THERAPEUTICS INC | $17.8M |
SLGCUSDSOMALOGIC INC | $17.5M |
ADMAADMA BIOLOGICS INC | $16.8M |
NUVLNUVALENT INC | $14.3M |
LYRALYRA THERAPEUTICS INC | $14.1M |
VTRSVIATRIS INC | $13.6M |
SAVACASSAVA SCIENCES INC | $13.1M |
BCABBIOATLA INC | $13.0M |
IMCRIMMUNOCORE HLDGS PLC | $12.3M |
NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | $12.0M |
BIIBBIOGEN INC | $11.7M |
ABSIABSCI CORPORATION | $11.6M |
ACRSACLARIS THERAPEUTICS INC | $11.4M |
SMFRUSDSEMA4 HOLDINGS CORP | $11.2M |
MRUSMERUS N V | $11.1M |
IMRXIMMUNEERING CORP | $11.0M |
HYPRHYPERFINE INC | $10.9M |
GRPHGRAPHITE BIO INC | $10.6M |
CATBUSDASTRIA THERAPEUTICS INC | $10.6M |
—AGILE THERAPEUTICS INC | $10.4M |
HRMYHARMONY BIOSCIENCES HLDGS IN | $10.2M |
—SUMMIT HEALTHCRE ACQUISTN CO | $9.9M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $9.9M |
KYMRKYMERA THERAPEUTICS INC | $9.8M |
—BCLS ACQUISITION CORP | $9.8M |
—RESEARCH ALLIANCE CORP II | $9.8M |
TYRATYRA BIOSCIENCES INC | $9.5M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $9.4M |
Page 1 of 2Next